ANI Pharmaceuticals Inc (ANIP)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-18,522	-7,091	27,015	35,547	18,779	13,381	-5,159	-26,327	-47,896	-67,789	-63,636	-62,819	-42,608	-22,107	-17,238	-15,468	-22,560	-23,760	-20,350	-1,536
Total assets	US$ in thousands	1,283,700	1,287,380	920,753	914,524	904,422	889,914	859,341	765,224	760,087	739,110	751,334	744,846	771,598	470,454	480,159	463,843	461,190	462,581	465,391	482,232
ROA		-1.44%	-0.55%	2.93%	3.89%	2.08%	1.50%	-0.60%	-3.44%	-6.30%	-9.17%	-8.47%	-8.43%	-5.52%	-4.70%	-3.59%	-3.33%	-4.89%	-5.14%	-4.37%	-0.32%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $-18,522K ÷ $1,283,700K
= -1.44%

The return on assets (ROA) for ANI Pharmaceuticals Inc has shown a fluctuating trend over the period from March 31, 2020, to December 31, 2024. It started with negative values, indicating that the company was not efficiently utilizing its assets to generate profits. The negative ROA values continued to decline until September 30, 2021, reaching a low of -4.70%.

From the fourth quarter of 2021 onwards, there was a gradual improvement in the ROA, with the metric turning positive by March 31, 2023. This positive trend continued to strengthen, reaching 3.89% by March 31, 2024. This indicates that the company was able to effectively generate profits relative to its total assets.

However, there was a slight decline in the ROA in the following quarters, with the metric dropping to -1.44% by December 31, 2024. Despite this slight decline, the overall trend shows a significant improvement in the company's efficiency in utilizing its assets to generate returns over the analyzed period.